Lowenstein Sandler LLP has advised Celldex Therapeutics, Inc., and Wilmer Cutler Pickering Hale and Dorr has represented the underwriters. Celldex Therapeutics, Inc. (Nasdaq: CLDX) has announced...
Celldex Therapeutics Raises $345 Million in Public Offering of Common Stock
Celldex Therapeutics’ $230.5 Million Common Stock Offering
Lowenstein Sandler advised Celldex Therapeutics, Inc. on the offering, and Wilmer Cutler Pickering Hale and Dorr advised the underwriters. Celldex Therapeutics, Inc. (Nasdaq: CLDX) (“Celldex”) announced the...
Celldex Therapeutics’ $287.5 Million Common Stock Offering
Lowenstein Sandler represented Celldex Therapeutics in the offering. Celldex Therapeutics, Inc. (Celldex) (Nasdaq: CLDX) executed its $287.5 million public offering of common stock. Jefferies, SVB Leerink,...



























